Discovery Sciences, Worldwide Research, Development and Medical, Pfizer, Groton, CT, USA.
Department of Biology, Almirall Research & Development, Barcelona, Spain.
Nat Rev Drug Discov. 2022 Dec;21(12):899-914. doi: 10.1038/s41573-022-00472-w. Epub 2022 May 30.
Many drugs, or their antecedents, were discovered through observation of their effects on normal or disease physiology. For the past generation, this phenotypic drug discovery approach has been largely supplanted by the powerful but reductionist approach of modulating specific molecular targets of interest. Nevertheless, modern phenotypic drug discovery, which combines the original concept with modern tools and strategies, has re-emerged over the past decade to systematically pursue drug discovery based on therapeutic effects in realistic disease models. Here, we discuss recent successes with this approach, as well as consider ongoing challenges and approaches to address them. We also explore how innovation in this area may fuel the next generation of successful projects.
许多药物或其前身是通过观察它们对正常或疾病生理的影响而发现的。在过去的几十年中,这种表型药物发现方法在很大程度上已经被强大但简化的调节特定感兴趣的分子靶标的方法所取代。然而,现代表型药物发现,它将原始概念与现代工具和策略相结合,在过去十年中重新出现,以系统地基于现实疾病模型中的治疗效果来进行药物发现。在这里,我们讨论了这种方法的最新成功案例,同时也考虑了正在面临的挑战和解决方法。我们还探讨了该领域的创新如何为下一代成功项目提供动力。